Loading stock research
Loading stock research…
No token price observed
Observation time unavailableUnavailable
Buy from your own wallet on Solana mainnet. You review and sign every transaction.
Checking whether mainnet purchases are available…
You sign in your own wallet. Ovelo never holds your keys or funds.
Daily closes of MDLN, the underlying share. A token’s rights, price and liquidity can differ from the share.
Research observed · Source: Yahoo Finance, Wikipedia (CC BY-SA)
What you would hold, where it trades and where these numbers come from.
Observation time unavailableUnavailable
The company behind MDLN.
MEDLINE (Medical Literature Analysis and Retrieval System Online, or MEDLARS Online) is a bibliographic database of life sciences and biomedical information. It includes bibliographic information for articles from academic journals covering medicine, nursing, pharmacy, dentistry, veterinary medicine, and health care. MEDLINE also covers much of the literature in biology and biochemistry, as well as fields such as molecular evolution. Compiled by the United States National Library of Medicine (NLM), MEDLINE is freely available on the Internet and searchable via PubMed and NLM's National Center for Biotechnology Information's Entrez system.
Observed · Source: Company profile
Momentum from daily closes of the underlying share.
Computed from daily closes of the underlying share, not the token. Not a recommendation.
Close of · Source: Yahoo Finance daily closesStale
Reported financials. They describe the company, not the token’s market value.
| Item | Period end | Value |
|---|---|---|
| Revenue (annual) | 31 Dec 2025 | $28.43B |
| Net income (annual) | 31 Dec 2025 | $1.16B |
| Diluted EPS (annual) | 31 Dec 2025 | 1.43 USD/share |
| Diluted EPS (annual) | 31 Dec 2024 | 0.66 USD/share |
| Diluted EPS (annual) | 31 Dec 2023 | 0.13 USD/share |
| Diluted EPS (annual) | 31 Dec 2022 | −0.01 USD/share |
| Total assets (annual) | 31 Dec 2025 | $38.48B |
| Total debt (annual) | 31 Dec 2025 | $12.63B |
| Operating cash flow (annual) | 31 Dec 2025 | $1.74B |
| Free cash flow (annual) | 31 Dec 2025 | $1.30B |
| Free cash flow (annual) | 31 Dec 2023 | $1.41B |
| Revenue (quarterly) | 30 Sept 2026 | $7.86B |
| Revenue (quarterly) | 30 Jun 2026 | $7.69B |
| Revenue (quarterly) | 31 Mar 2026 | $7.35B |
| Revenue (quarterly) | 31 Dec 2025 | $7.79B |
| Revenue (quarterly) | 31 Mar 2025 | $6.64B |
| Net income (quarterly) | 30 Sept 2026 | $195.00M |
| Net income (quarterly) | 30 Jun 2026 | $60.00M |
| Net income (quarterly) | 31 Mar 2026 | $129.00M |
| Net income (quarterly) | 31 Dec 2025 | $182.00M |
| Net income (quarterly) | 31 Mar 2025 | $322.00M |
| Diluted EPS (quarterly) | 30 Sept 2026 | 0.22 USD/share |
| Diluted EPS (quarterly) | 30 Jun 2026 | 0.07 USD/share |
| Diluted EPS (quarterly) | 31 Mar 2026 | 0.16 USD/share |
| Diluted EPS (quarterly) | 31 Dec 2025 | −0.01 USD/share |
| Diluted EPS (quarterly) | 30 Sept 2025 | 0.40 USD/share |
Reported dividends, splits and filings, each linked to its source.
No dividends, splits or filings were found.
Recent headlines about the company.
No recent news was found for this company.